OR13C7

Across TCGA pan-cancer cohorts, OR13C7 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR13C7 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR13C7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR13C7 expression acts as an unfavorable survival marker.

STAD, ESCA, and DLBC are the cancer types where OR13C7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.439	0.756	<.001	72	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
UCEC	OS	Tertile	All	0.661	0.879	<.001	36	view →
KIRP	DFS	Tertile	All	0.785	0.931	.007	27	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	18	view →
HNSC	OS	Tertile	II,III,IV	0.196	0.710	.023	18	view →
PAAD	DFS	Tertile	All	0.163	0.508	.040	9	view →
BLCA	DFS	Tertile	III,IV	0.250	0.575	.042	9	view →
READ	OS	Tertile	IV	0.557	0.883	.040	9	view →
THYM	DFS	Tertile	III,IV	0.205	0.772	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR13C7–STAD (OS)

Open the STAD breakdown →